Distillate Capital Partners LLC Biogen Inc. Transaction History

Distillate Capital Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$187.54 - $223.02 $5.33 Million - $6.33 Million	-28,398 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$193.77 - $244.14 $2.03 Million - $2.55 Million	10,451 Added 58.23%	28,398 $5.98 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $1.71 Million - $2.2 Million	7,648 Added 74.26%	17,947 $4.31 Million
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $211,110 - $275,311	-746 Reduced 6.75%	10,299 $2.91 Million
Q2 2021 Jul 30, 2021	SELL	$259.0 - $414.71 $370,111 - $592,620	-1,429 Reduced 11.46%	11,045 $3.83 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $1.22 Million - $1.43 Million	5,031 Added 67.59%	12,474 $3.49 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $1.76 Million - $2.65 Million	7,443 New	7,443 $1.81 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Distillate Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Distillate Capital Partners LLC with notifications on news.